Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
0.1%
1w
5.7%
1m
5.1%
3m
15.0%
6m
23.1%
1y
22.5%
all
5.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 153 0.1%
143
185
Company Overview

Sales
8,871 Cr
Growth: 1.7%
Profit after Tax
-184 Cr
Growth: 314.5%
Mid Cap
20,331 Cr
P/S: 2.3x
Industry P/S: 2.2x
Fundamentals

Sales (Cr) ₹ 8,871
Growth 1.7%
EBITDA 11.5%
P/S 2.3x
Dividend 0.1%
P/E -123.5x
Book Value ₹ 58.6
PEG Ratio -74.5x
ROE -2.3%
P/B 2.6x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Investors (6)
Followers (2)